SLC2A3 and Alzheimer disease: The accumulation of amyloid β peptide (Aβ), the most characteristic feature of AD, may interfere with the SNARE-mediated docking of GLUT3 and GLUT4 to the plasma membrane, resulting in reduced glucose uptake in neurons22,32,33.